Marcel Walser, Ph.D.Senior Director Research at Molecular Partners
Marcel received his MSc in molecular biology and developed novel screening methods for biotechnological applications during his PhD at the ETH Zurich, Switzerland. Marcel joined Molecular Partners in 2011. Since then, he leads several activities within the Lead Generation Department to enable developable DARPin® candidates for various therapeutic programs. Recently, he was part of a team to develop a novel platform for highly specific peptide:MHC DARPin® binders in multi-specific T-cell engager formats. In March 2020, Marcel started and lead the research activities to develop therapeutic DARPin® antivirals against SARS-CoV-2, which are currently in clinical development.